oral glp 1 meds GLP-1 Orforglipron Is Approved for Obesity crave less oral glp 1 meds Compounded

Because these drugs are so revolutionary and there is little in the way of competition, people who can afford them are willing to pay a premium

Goal: Type 2 diabetes management (A1C reduction) If you prefer once-weekly injections: Semaglutide (Ozempic), tirzepatide (Mounjaro), dulaglutide (Trulicity), or efpeglenatide (Eperzan) If you prefer daily injections: Liraglutide (Victoza) or lixisenatide (Adlyxin) If you prefer oral medication: Semaglutide (Rybelsus) If cost is the primary concern: Compounded semaglutide or compounded tirzepatide (if eligible under shortage provisions) Goal: Weight loss (obesity or overweight with comorbidities) If you want maximum weight loss: Retatrutide (Retara, triple agonist, 24% mean loss) or tirzepatide (Zepbound, dual agonist, 20% to 22% mean loss) If you want proven long-term safety data: Semaglutide (Wegovy, 15% to 17% mean loss, 5+ years post-approval data) If you prefer oral medication: Orforglipron (Orfoglip, 15% mean loss, oral once daily) If cost is the primary concern: Compounded semaglutide or compounded tirzepatide Goal: Both diabetes and weight loss If you have significant obesity (BMI over 35): Tirzepatide (Mounjaro for diabetes indication, Zepbound for obesity indication

Non-concentrated juices and teas can count toward your water consumption

Semaglutide has been found to protect endothelial progenitor cells by inhibiting the expression of miR-155 (a microRNA) in macrophage exosomes [62]

The most common cause

I finally felt like my body was working with me, not against me. GLP-1s didnt fix everything